The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes
Open accessAbstract
oronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is causing a dramatic pandemic. 1ombardy, in northern Italy, is one of the most affected regions worldwide. 2ardiovascular complications occur frequently in patients with COVID-19, 3 with challenges in acute management.We aimed to evaluate incidence, clinical presentation, angiographic findings, and clinical outcomes of ST-elevation myocardial infarction (STEMI) in patients with COVID-19.All hospitals with catherization laboratories in Lombardy were contacted to collect cases of patients with confirmed COVID-19 who underwent an urgent coronary angiogram because of STEMI between February 20, 2020 (date of first COVID-19 case in Lombardy) and March 30, 2020. 2 Data were collected retrospectively, in anonymized fashion without any sensitive data, therefore not requiring institutional review board approval.COVID-19 was confirmed with reverse transcription-polymerase chain reaction assays.STEMI was defined based on the presence of typical symptoms associated with ST-segment elevation or new left bundle-branch block. 4A stenosis was considered as the culprit lesion in case of angiographic evidence of thrombotic occlusion/subocclusion.Obstructive coronary artery disease was defined based on the angiographic evidence of a stenosis >50% on visual estimation.A total of 28 patients with COVID-19 with STEMI were included.All patients met the guideline definition of STEMI 4 with localized ST-elevation (25 patients, 89.3%) or new left bundle-branch block (3 patients, 10.7%), and all were treated in the setting of emergent activation.The Table displays a detailed overview of each included patient.The mean age was 68±11 years, 8 patients (28.6%) were women, 20 (71.4%) had arterial hypertension, 9 (32.1%) had diabetes mellitus, 8 (28.6%) had chronic kidney disease, and 3 (10.7%)had a previous myocardial infarction.For 24 patients (85.7%), the STEMI represented the first clinical manifestation of COVID-19, and they did not have a COVID-19 test result at the time of coronary angiography.The remaining 4 patients had STEMI during hospitalization for COVID-19.Twenty-two patients (78.6%) presented with typical chest pain associated with or not associated with dyspnea, and 6 patients (21.4%) had dyspnea without chest pain.On echocardiography, 23 patients (82.1%) had localized wall motion abnormalities, 3 (10.7%)had diffuse hypokinesia, and 2 (7.1%) did not have abnormalities.The left ventricular ejection fraction was <50% in 17 patients (60.7%).All patients underwent urgent coronary angiography, and none was treated with fibrinolysis.Out of 28 patients, 17 patients (60.7%) had evidence of a culprit lesion requiring revascularization, and 11 patients (39.3%) did not have obstructive coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic
Welt, F. G. P., Shah, P. B., Aronow, H. D., Bortnick, A. E., Henry, T. D., Sherwood, M. W., Young, M. N., Davidson, L. J., Kadavath, S., Mahmud, E., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.021 · Cited by 411
Zeng, J., Huang, J., & Pan, L. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05993-9 · Cited by 221
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak
Stefanini, G. G., Azzolini, E., & Condorelli, G. (2020) · Circulation · doi:10.1161/circulationaha.120.047070 · Cited by 57
Self-citation
Cited by
Interplay between inflammation and thrombosis in cardiovascular pathology
Stark, K., & Massberg, S. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00552-1 · Cited by 1,033
Katsoularis, I., Fonseca-Rodríguez, O., Farrington, P., Lindmark, K., & Fors Connolly, A.-M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00896-5 · Cited by 582
Abdi, A., AlOtaiby, S., Badarin, F. A., Khraibi, A., Hamdan, H., & Nader, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112518 · Cited by 47
Metadata
- Authors
- Stefanini, G. G., Montorfano, M., Trabattoni, D., Andreini, D., Ferrante, G., Ancona, M., Metra, M., Curello, S., Maffeo, D., Pero, G., Cacucci, M., Assanelli, E., Bellini, B., Russo, F., Ielasi, A., Tespili, M., Danzi, G. B., Vandoni, P., Bollati, M., Barbieri, L., Oreglia, J., Lettieri, C., Cremonesi, A., Carugo, S., Reimers, B., Condorelli, G., & Chieffo, A.
- Venue
- Circulation
- Published
- 2020-06-23
- Volume
- 141
- Issue
- 25
- Pages
- 2113-2116
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3022384443
- Cited by
- 426
- References
- 5
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. https://app.cochat.ai/papers/10.1161/circulationaha.120.047525
- The paper
- Stefanini, G. G., Montorfano, M., Trabattoni, D., Andreini, D., Ferrante, G., Ancona, M., Metra, M., Curello, S., Maffeo, D., Pero, G., Cacucci, M., Assanelli, E., Bellini, B., Russo, F., Ielasi, A., Tespili, M., Danzi, G. B., Vandoni, P., Bollati, M., . . . Chieffo, A. (2020). ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation. https://doi.org/10.1161/circulationaha.120.047525
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.